'Corbevax' - 3 News Result(s)
India News | Press Trust of India | Friday September 3, 2021Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.
India News | Press Trust of India | Friday August 6, 2021Union Health Minister Mansukh Mandaviya on Friday held separate meetings with Serum Institute of India CEO Adar Poonawalla and Biological-E MD Mahima Dalta to discuss issues regarding COVID-19 vaccines.
India News | Reported by Vishnu Som, Edited by Harish Pullanoor | Thursday June 17, 2021Biological E's made-in-India vaccine is expected to have 90 per cent effectiveness against Covid and will likely be a gamechanger in the fight against the pandemic, says a top doctor on a government advisory panel.
'Corbevax' - 3 News Result(s)
- India News | Press Trust of India | Friday September 3, 2021Biological E has received approval for conducting phase II/III human clinical trial of COVID-19 vaccine candidate Corbevax on children above five years and adolescents, the Department of Biotechnology said today.
- India News | Press Trust of India | Friday August 6, 2021Union Health Minister Mansukh Mandaviya on Friday held separate meetings with Serum Institute of India CEO Adar Poonawalla and Biological-E MD Mahima Dalta to discuss issues regarding COVID-19 vaccines.
- India News | Reported by Vishnu Som, Edited by Harish Pullanoor | Thursday June 17, 2021Biological E's made-in-India vaccine is expected to have 90 per cent effectiveness against Covid and will likely be a gamechanger in the fight against the pandemic, says a top doctor on a government advisory panel.
Your search did not match any documents
A few suggestions
- Make sure all words are spelled correctly
- Try different keywords
- Try more general keywords
Check the NDTV Archives:https://archives.ndtv.com
